Kaveh Katebian, BA MA

Chief Executive Officer
Ensho Health, Canada

Poster(s):

• (P051) CHARACTERIZATION OF PATIENTS SUB-OPTIMALLY TREATED FOR DYSLIPIDEMIA MANAGEMENT IN SECONDARY PREVENTION FOLLOWING THE PUBLICATION OF THE 2021 CCS DYSLIPIDEMIA GUIDELINES
  Saturday, October 26, 2024

  9:45 AM – 10:45 AM PT